Sage Therapeutics
SAGE
#7026
Rank
HK$4.24 B
Marketcap
HK$67.56
Share price
0.00%
Change (1 day)
8.62%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -HK$2.35 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are HK$70.41 Million. In 2024 the company made an earning of -HK$3.12 Billion, an increase over its 2023 earnings that were of -HK$4.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$2.35 Billion-24.82%
2024 -HK$3.12 Billion-26.01%
2023 -HK$4.22 Billion1.63%
2022 -HK$4.15 Billion16.36%
2021 -HK$3.57 Billion-175.55%
2020 HK$4.71 B-189.1%
2019 -HK$5.3 Billion82.43%
2018 -HK$2.91 Billion38.04%
2017 -HK$2.11 Billion69.9%
2016 -HK$1.24 Billion68.25%
2015 -HK$0.74 Billion179.48%
2014 -HK$0.27 Billion84.98%
2013 -HK$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-HK$0.37 Billion-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
HK$0.27 B-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
HK$3.98 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-HK$0.46 Billion-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA